PKO Investment Management Joint-Stock Co

Position in NBIX — Neurocrine Biosciences Inc

CIK 2059321 WARSAW, R9

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$235,956

+$51,520 QoQ

Shares Held

1,400

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#574

of 768 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PKO Investment Management Joint-Stock Co holds $1,376,421 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (17.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	14,000	$474,320
2	ZTS	Zoetis Inc.	5,500	$395,230
3	UTHR	UNITED THERAPEUTICS Corp	500	$270,915
4	NBIX	Neurocrine Biosciences Inc This page	1,400	$235,956

All Filings in NBIX

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$235,956	1,400	0.0%	Shares	Sole	2026-07-20
2026-03-31	$184,436	1,400	+7.7%	Shares	Sole	2026-04-17
2025-12-31	$184,379	1,300	—	Shares	Sole	2026-02-02
No filing history on record for this holder in this stock.